CHARLOTTESVILLE, Va.– ZyGEM Corp. Ltd., a developer and marketer of innovative products for the analysis of DNA and other nucleic acids, today announced that it has signed an OEM agreement with Saudi Diagnostics Limited (SDL) for ZyGEM’s DNA and RNA extraction kits. SDL was established by the King Faisal Specialist Hospital & Research Centre (KFSH&RC) […]
Basel, Switzerland – Rolf Soiron, Chairman of the Board of Lonza, commenting on today’s announcement, said:“With the acquisition of Arch in 2011 Lonza achieved another step in its transformation towards a global Life Science company. This continuous change characterized the past years and Stefan Borgas has led this process as Lonza’s CEO. The Board of […]
SAN DIEGO — Illumina, Inc. ILMN -0.19%, a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function (the “Company”), announced today that its Board of Directors (the “Board”) adopted a Rights Agreement, pursuant to which one preferred stock purchase right will be distributed as […]
INDIANAPOLIS — Roche announced today that it has entered into a strategic alliance with Technoclone, a reagent specialist in thrombosis and cardiovascular diagnostics based in Vienna, Austria, to co-develop a complete range of coagulation assays. The alliance supports plans Roche announced in October 2011 to develop a new line of analyzers for the central coagulation […]
The Tankyrase 1 Activity Assay from AMSBIO are highly sensitive screening kits for the identification of Tankyrase 1 inhibitors in an in vitro system. These new kits are the latest addition to the comprehensive range of high performance PARP assay kits, enzymes & antibodies available from AMSBIO to assist scientists with their DNA damage research. […]
BASEL, Switzerland — Roche a leader in research-focused healthcare with combined strengths in pharmaceuticals, life science tools and diagnostics, announced today that it has commenced a cash tender offer to acquire all outstanding shares of Illumina, Inc. (NASDAQ: ILMN). The offer and withdrawal rights are scheduled to expire at 12:00 midnight, New York City time, […]
BASEL, Switzerland — Roche today responded to an announcement from Illumina, Inc. ILMN -0.19% that its Board of Directors has adopted a shareholder rights plan. Although not unexpected, Roche is disappointed that the Illumina Board of Directors has been unwilling to participate in substantive discussions with Roche regarding a negotiated transaction and has instead adopted […]
SAN DIEGO–Illumina, Inc. (NASDAQ:ILMN), a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function, tonight acknowledged the announcement by Roche (RHHBY.PK) that Roche has made an unsolicited acquisition proposal and intends to commence a tender offer to acquire all of the outstanding shares of […]
Basel – Together with Illumina, Roche will strengthen its position in the Life Science and Diagnostics market, with complementary technologies in Genetics/Genomics research and routine diagnostics. Roche and Illumina’s combined capabilities and global reach will help accelerate the transition of sequencing into clinical and routine diagnostics. Roche intends to combine its existing Applied Science business […]
Worthington Biochemical’s updated 2012 Tissue Dissociation Guide is now available to assist researchers with selecting enzymes, developing and optimizing protocols and better understanding the process of enzymatic primary cell isolation and tissue dissociation. The guide also discusses the enzymes most commonly used, their handling and specificity, and includes hundreds of new detailed cell and species-specific […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
